Randomized controlled double-blind trial of methylprednisolone versus placebo in patients with post-COVID-19 syndrome and cognitive deficits: study protocol of the post-corona-virus immune treatment (PoCoVIT) trial

被引：0
|
作者：
Christiana Franke
Vanessa Raeder
Fabian Boesl
Benno Bremer
Lucas C. Adam
Ameli Gerhard
Irina Eckert
Anneke Quitschau
Anne Pohrt
Susen Burock
Lisa Bruckert
Carmen Scheibenbogen
Harald Prüß
Heinrich J. Audebert
机构：
[1] Charité – Universitätsmedizin Berlin,Department of Neurology and Experimental Neurology, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin
[2] Charité Campus Benjamin Franklin,Corporate Member of Freie Universität Berlin and Humboldt
[3] Charité - Universitätsmedizin Berlin,Universität zu Berlin, Institute of Biometry and Clinical Epidemiology
[4] Charité - Universitätsmedizin Berlin,Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Clinical Trial Office
[5] Charité - Universitätsmedizin Berlin,Department of Neurology, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin
[6] Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Institute of Medical Immunology, Corporate Member of Freie Universität Berlin and Humboldt
[7] Charité – Universitätsmedizin Berlin,Universität zu Berlin
来源：
Neurological Research and Practice | / 6卷
关键词：
Post-COVID; Long-COVID; Glucocorticoids; Treatment; Methylprednisolone; Placebo-controlled trial protocol; Pathophysiology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Randomized controlled double-blind trial of methylprednisolone versus placebo in patients with post-COVID-19 syndrome and cognitive deficits: study protocol of the post-corona-virus immune treatment (PoCoVIT) trial
    Franke, Christiana
    Raeder, Vanessa
    Boesl, Fabian
    Bremer, Benno
    Adam, Lucas C.
    Gerhard, Ameli
    Eckert, Irina
    Quitschau, Anneke
    Pohrt, Anne
    Burock, Susen
    Bruckert, Lisa
    Scheibenbogen, Carmen
    Pruess, Harald
    Audebert, Heinrich J.
    NEUROLOGICAL RESEARCH AND PRACTICE, 2024, 6 (01):
  • [2] Presenting the Post-Corona-Virus Immune Treatment trial (PoCoVIT) - a study outline
    Bremer, B.
    Raeder, V.
    Boesl, F.
    Audebert, H.
    Franke, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 391 - 391
  • [3] Cognitive rehabilitation in post-COVID-19 condition: A study protocol for a randomized controlled trial
    Hagen, Bjorn Ingulfsvann
    Lerdal, Anners
    Soraas, Arne
    Landro, Nils Inge
    Bo, Ragnhild
    Smastuen, Milada Cvancarova
    Becker, Jacqueline
    Stubberud, Jan
    CONTEMPORARY CLINICAL TRIALS, 2022, 122
  • [4] Individualized Homeopathic Medicinal Products in the Treatment of Post-COVID-19 Conditions: A Double-Blind, Randomized, Placebo-Controlled, Feasibility Trial
    Rana, Abhijit
    Bhattacharya, Pulakendu
    Ganguly, Subhasish
    Saha, Sangita
    Naskar, Satyajit
    Ghosh, Shubhamoy
    Shaikh, Abdur Rahaman
    Koley, Munmun
    Saha, Subhranil
    Mukherjee, Shyamal Kumar
    JOURNAL OF INTEGRATIVE AND COMPLEMENTARY MEDICINE, 2025, 31 (01): : 64 - 74
  • [5] Fuzheng Huayu tablets for treating pulmonary fibrosis in post-COVID-19 patients: a multicenter, randomized, double-blind, placebo-controlled trial
    Jing, Fei
    Wang, Wei
    Ke, Jia
    Huang, Tingrong
    Jiang, Bo
    Qiu, Qiwu
    Huang, Jihan
    Zhan, Songhua
    Zhang, Wei
    Wu, Hui
    Su, Wen
    Feng, Jiawen
    Peng, Yuan
    Zhao, Zhimin
    Xing, Feng
    Liu, Chenghai
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [6] Effect of famotidine on cognitive and behavioral dysfunctions induced in post-COVID-19 infection: A randomized, double-blind, and placebo-controlled study
    Momtazmanesh, Sara
    Ansari, Sahar
    Izadi, Zahra
    Shobeiri, Parnian
    Vatankhah, Venus
    Seifi, Arash
    Ghiasvand, Fereshteh
    Bahrami, Mahboobeh
    Salehi, Mohammdreza
    Noorbala, Ahmad Ali
    Akhondzadeh, Shahin
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2023, 172
  • [7] Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial
    Ballou, Sarah
    Kaptchuk, Ted J.
    Hirsch, William
    Nee, Judy
    Iturrino, Johanna
    Hall, Kathryn T.
    Kelley, John M.
    Cheng, Vivian
    Kirsch, Irving
    Jacobson, Eric
    Conboy, Lisa
    Lembo, Anthony
    Davis, Roger B.
    TRIALS, 2017, 18
  • [8] Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial
    Sarah Ballou
    Ted J. Kaptchuk
    William Hirsch
    Judy Nee
    Johanna Iturrino
    Kathryn T. Hall
    John M. Kelley
    Vivian Cheng
    Irving Kirsch
    Eric Jacobson
    Lisa Conboy
    Anthony Lembo
    Roger B. Davis
    Trials, 18
  • [9] Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial
    McIntyre, Roger S.
    Phan, Lee
    Kwan, Angela T. H.
    Mansur, Rodrigo B.
    Rosenblat, Joshua D.
    Guo, Ziji
    Le, Gia Han
    Lui, Leanna M. W.
    Teopiz, Kayla M.
    Ceban, Felicia
    Lee, Yena
    Bailey, Julia
    Ramachandra, Ranuk
    Di Vincenzo, Joshua
    Badulescu, Sebastian
    Gill, Hartej
    Drzadzewski, Pawel
    Subramaniapillai, Mehala
    BRAIN, 2024, 147 (03) : 849 - 857
  • [10] Efficacy of amantadine in patients hospitalized with COVID-19: Study protocol of a randomized, double-blind, placebo-controlled trial
    Lopiano, Leonardo
    Artusi, Carlo Alberto
    Bozzali, Marco
    Ancidoni, Antonio
    Ciccone, Giovannino
    De Rosa, Francesco
    Vanacore, Nicola
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
12345